Recursion Pharmaceuticals Inc stock is traded at $2.59, with a volume of 27,959,812. It is down -11.02% in the last 24 hours and down -25.40% over the past month. Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
Previous Close:
$2.91
Open:
$2.95
24h Volume:
27,959,812
Relative Volume:
1.43
Market Cap:
$1.61B
Revenue:
$66.41M
Net Income/Loss:
-$559.78M
P/E Ratio:
-
EPS:
-$1.20
Net Cash Flow:
-$328.09M
1W Performance:
-27.18%
1M Performance:
-25.40%
6M Performance:
-11.77%
1Y Performance:
-37.26%
1-Day Range:
$2.50$2.95
1-Week Range:
$2.50$3.72
52-Week Range:
$2.50$5.24
Recursion Pharmaceuticals Inc Stock (RXRX) Company Profile
Name
Recursion Pharmaceuticals IncSector
HealthcareIndustry
BiotechnologyPhone
(385) 269-0203Address
41S RIO GRANDE STREET, SALT LAKE CITY, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS